Compare MPLX LP (MPLX) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MPLX LP vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? MPLX LP trades at $56.35 (market cap $58.11B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.95 (market cap $25.27B). The key difference: MPLX LP is far larger — about 2.3× Royalty Pharma plc Class A Ordinary Shares's market cap, and MPLX LP pays the higher dividend (7.51%). Which is the better fit depends on your goals.
| MPLX | RPRX | |
|---|---|---|
Market Cap | $58.11B | $25.27B |
Volume | 687,483 | 3,671,183 |
Sector | Energy | Health |
52-Week High | $60.51 | $63.96 |
52-Week Low | $47.80 | $35.44 |
Enterprise Value | $83.22B | $32.50B |
Dividend Yield | 7.51% | 1.66% |
Typical Hold Time | — | 1 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MPLX trades at $56.12, down 1.63% with a bearish technical signal. The stock shows strong fundamentals with a 12.33 P/E ratio, 40.45% net income margin, and consistent dividend payments. Recent earnings show mixed results with Q4 2025 beating expectations but subsequent quarters missing targets. Analyst consensus remains strongly bullish with 19 buy ratings and a $63.80 price target, representing 13.7% upside potential from current levels.
The outlook remains positive given MPLX's resilient midstream business model with fee-based revenues insulating it from energy price volatility. Key risks include potential energy market downturns and execution challenges in the Permian Basin expansion. The company's strong cash flow generation supports its 8% dividend yield, making it attractive for income investors seeking energy exposure with reduced commodity price sensitivity.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
